Study summary · research use only
Kisspeptin system-physiology and clinical perspectives
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This review (species not specified) summarizes knowledge on kisspeptin, described as altering migration properties of some cancer cells and regulating the reproductive axis. Based on a PubMed search, the authors describe kisspeptin's role in reproductive axis regulation and puberty, interactions with centrally acting metabolic factors, and its presence outside the reproductive tract in the pancreas, liver, and adipose tissue. The review also describes kisspeptin's reported role in altering metastatic potential in cancer types including melanoma, breast, colorectal, gastric, thyroid, and hepatocellular carcinoma, and in inducing dormancy in disseminated tumor cells, said to suppress metastatic colonization in multiple organs. The authors suggest the kisspeptin system could in future provide diagnostic tests and therapeutic targets for reproductive disorders and cancer prognosis.
Abstract
To summarize the state of knowledge on kisspeptin, a factor that alters the migration properties of some types of cancer cell and also plays an important role in the control of the reproductive axis. PubMed search, identifying the most recent relevant information. This review describes the physiological aspects about the regulation of kisspeptin release and its place in the regulation of reproductive axis. Kisspeptin's role in puberty and its interaction with male and female reproductive axis are discussed along with potential clinical perspectives. Further analysis was made of the interaction of kisspeptin with centrally acting metabolic factors and on the presence of the kisspeptin system in some organs outside the reproductive tract: pancreas, liver, and adipose tissue. The kisspeptin system is a factor that alters the metastatic potential in various cancer types-malignant melanoma, breast cancer, colorectal cancer, gastric carcinoma, thyroid carcinoma, hepatocellular carcinoma, etc. Additionally, kisspeptin has also been reported to induce dormancy in already disseminated tumor cells, thus suppressing metastatic colonization in multiple organs. The kisspeptin system could in future provide additional diagnostic tests and even therapeutic targets and procedures for the management of some reproductive disorders. As a factor involved in suppression of metastasis, it may in future have significant value for prognosis and/or follow-up in various cancer types.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.